GLA c.773G>T ;(p.G258V)

Variant ID: X-100653801-C-A

NM_000169.2(GLA):c.773G>T;(p.G258V)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports
Šimčíková, Daniela D; Heneberg, Petr P
Publication Date: 2019-12-09

Variant appearance in text: GLA: G258V
PubMed Link: 31819097
Variant Present in the following documents:
  • 41598_2019_54976_MOESM2_ESM.xlsx, sheet 8
View BVdb publication page



Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?

Plos One
Ravarotto, Verdiana V; Carraro, Gianni G; Pagnin, Elisa E; Bertoldi, Giovanni G; Simioni, Francesca F; Maiolino, Giuseppe G; Martinato, Matteo M; Landini, Linda L; Davis, Paul A PA; Calò, Lorenzo A LA
Publication Date: 2018

Variant appearance in text: GLA: 773G>T
PubMed Link: 30261035
Variant Present in the following documents:
  • Main text
  • pone.0204618.pdf
View BVdb publication page



Comparative study of structural changes caused by different substitutions at the same residue on α-galactosidase A.

Plos One
Saito, Seiji S; Ohno, Kazuki K; Sakuraba, Hitoshi H
Publication Date: 2013

Variant appearance in text: GLA: G258V
PubMed Link: 24386359
Variant Present in the following documents:
  • Main text
  • pone.0084267.pdf
View BVdb publication page



Pharmacological chaperone therapy for Fabry disease.

Proceedings Of The Japan Academy. Series B, Physical And Biological Sciences
Ishii, Satoshi S
Publication Date: 2012

Variant appearance in text: GLA: G258V
PubMed Link: 22241068
Variant Present in the following documents:
  • pjab-88-018.pdf
View BVdb publication page